Multiple peripheral inflammatory markers in adolescents with major depressive disorder treated with repeated esketamine infusions: results from a randomized controlled trial.
Xiaofeng Lan, Zitao Wu, Chengyu Wang, Guanxi Liu, Muqin Zhang, Weicheng Li, Zhanjie Luo, Junhao Shen, Ziying Chen, Yuping Ning, Yanling Zhou
J Affect Disord February 23, 2026 DOI: 10.1016/j.jad.2026.121488 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Randomized controlled trial Peer reviewed |
|---|---|
| Population | Adolescents with major depressive disorder |
| Intervention | Esketamine |
| Topics | Depression Esketamine |
| Key findings | Repeated esketamine infusions were associated with changes in peripheral inflammatory markers in adolescents with major depressive disorder. |
Abstract
Multiple peripheral inflammatory markers in adolescents with major depressive disorder treated with repeated esketamine infusions: results from a randomized controlled trial.